GERMANY-HEALTH-VIRUS-BIONTECH-VACCINES

Employees in cleanroom suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine at the new manufacturing site of German company BioNTech on March 27, 2021 in Marburg, central Germany. - German firm BioNTech said on March 30, 2021 it was on track to manufacture 2.5 billion doses of its Covid-19 vaccine this year with US partner Pfizer, 25 percent more than previously expected. (Photo by Thomas Lohnes / AFP) (Photo by THOMAS LOHNES/AFP via Getty Images)
Employees in cleanroom suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine at the new manufacturing site of German company BioNTech on March 27, 2021 in Marburg, central Germany. - German firm BioNTech said on March 30, 2021 it was on track to manufacture 2.5 billion doses of its Covid-19 vaccine this year with US partner Pfizer, 25 percent more than previously expected. (Photo by Thomas Lohnes / AFP) (Photo by THOMAS LOHNES/AFP via Getty Images)
GERMANY-HEALTH-VIRUS-BIONTECH-VACCINES
EINE LIZENZ KAUFEN
Wie darf ich dieses Bild verwenden?
475,00 €
EUR

DETAILS

Einschränkungen:
Bei kommerzieller Verwendung sowie für verkaufsfördernde Zwecke kontaktieren Sie bitte Ihr lokales Büro. Vollständige redaktionelle Rechte in Großbritannien, USA, Irland, Italien, Spanien, Kanada (außer Quebec). Eingeschränkte redaktionelle Rechte in allen anderen Ländern. Wenden Sie sich bitte an Ihr lokales Büro.“The erroneous mention[s] appearing in the metadata of this photo by Thomas Lohnes has been modified in AFP systems in the following manner: [embargo is March 31, 00:01] instead of [April 1, 00:01].
Bildnachweis:
THOMAS LOHNES / Kontributor
Redaktionell #:
1232019247
Kollektion:
AFP
Erstellt am:
27. März 2021
Hochgeladen am:
Lizenztyp:
Lizenzpflichtig
Releaseangaben:
Kein Release verfügbar. Weitere Informationen
Quelle:
AFP
Barcode:
AFP
Objektname:
AFP_96W2UJ
Max. Dateigröße:
6048 x 4024 px (51,21 x 34,07 cm) - 300 dpi - 7 MB